手术时长对组织扩张器乳房再造30天结局的影响
该回顾性队列纳入1874例组织扩张器乳房再造患者(633例单侧、1241例双侧),分析手术时长与30天并发症的关系。单侧每延长10分钟,皮瓣坏死(aOR 1.04)和计划外再手术(aOR 1.03)风险升高;双侧每延长10分钟,皮瓣坏死(aOR 1.02)、计划外再入院(aOR 1.02)和手术部位感染(aOR 1.02)风险升高。
要点
- 单侧再造手术每延长10分钟,皮瓣坏死aOR 1.04、再手术aOR 1.03。
- 双侧再造手术每延长10分钟,皮瓣坏死、再入院、感染aOR均为1.02。
- 手术时长可能是短期并发症的预测指标,但或仅反映病例复杂度。
核心结论
- 单侧和双侧组织扩张器乳房再造中,较长手术时长均与皮瓣坏死风险升高相关。
- 手术时长可能作为短期并发症的重要预测指标,但可能只是病例复杂度的替代标志。
- 尚需进一步研究优化术中效率与标准化流程能否改善临床结局。
研究设计与样本
- 回顾性队列分析,纳入1874例组织扩张器乳房再造患者,其中单侧633例、双侧1241例。
- 采用逻辑回归模型估计手术时长每增加10分钟的比值比(OR),分别针对单侧和双侧病例。
- 构建未校正和分层校正(aOR)模型,评估30天术后结局。
主要发现
- 单侧病例中,手术时长每增加10分钟与皮瓣坏死风险升高显著相关(aOR 1.04;95% CI 1.01-1.07)。
- 单侧病例中,手术时长每增加10分钟与计划外再手术风险升高显著相关(aOR 1.03;95% CI 1.00-1.06)。
- 双侧病例中,手术时长每增加10分钟与皮瓣坏死风险升高显著相关(aOR 1.02;95% CI 1.00-1.05)。
- 双侧病例中,手术时长每增加10分钟与计划外再入院风险升高显著相关(aOR 1.02;95% CI 1.00-1.04)。
- 双侧病例中,手术时长每增加10分钟与手术部位感染风险升高显著相关(aOR 1.02;95% CI 1.00-1.03)。
临床怎么用
- 在组织扩张器乳房再造中,可将手术时长作为短期并发症风险的参考指标。
- 对手术时间较长者应加强皮瓣坏死、感染及再入院风险的监测。
- 优化术中效率和标准化流程能否改善结局尚需进一步研究验证。
局限性
- 手术时长可能仅是病例复杂度的替代标志,而非独立因果因素。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Operative duration has been associated with increased risk of postoperative complications in various surgical disciplines. However, its relationship with adverse outcomes in tissue expander-based (TE) breast reconstruction remains underexplored. METHODS: We conducted a retrospective cohort analysis of 1874 patients (633 unilateral, 1241 bilateral) undergoing TE-based breast reconstruction. We evaluated the association between operative time and 30-day postoperative outcomes including hematoma, seroma, mastectomy skin flap necrosis (MSFN), unplanned readmission, surgical site infection (SSI), and unplanned reoperation. Logistic regression models were used to estimate odds ratios (OR) for each outcome per 10-minute increase in operative duration for unilateral and bilateral cases, respectively. Both unadjusted and hierarchical adjusted (aOR) models were constructed. RESULTS: Among unilateral cases, a 10-minute increase in operation duration was significantly associated with higher odds of MSFN (aOR: 1.04; 95% CI, 1.01-1.07) and unplanned reoperation (aOR: 1.03; 95% CI, 1.00-1.06). In bilateral cases, operative duration per 10-minute increase demonstrated similar results with statistically significant increases in MSFN (aOR: 1.02; 95% CI, 1.00-1.05), unplanned readmission (aOR: 1.02; 95% CI, 1.00-1.04), and SSI (aOR: 1.02; 95% CI, 1.00-1.03). CONCLUSIONS: Longer operative time was consistently associated with increased odds of MSFN in both unilateral and bilateral TE-based breast reconstructions. These findings suggest that operative duration may serve as an important predictor of short-term complications, though it likely acts as a surrogate marker for case complexity. Further investigation is warranted to determine whether optimizing intraoperative efficiency and standardizing workflows can improve clinical outcomes.
引用
- Ibrahim Y, Zywica M, Alnaseri T, et al. Impact of operative time on 30-day surgical outcomes following tissue expander-based breast reconstruction. J Plast Reconstr Aesthet Surg. 2026. PMID: 42349348. doi:10.1016/j.bjps.2026.05.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。